Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Asha Konde · SciRah

Researcher profile · Semantic Scholar

Asha Konde

Share profile

Asha Konde — researcher profile on SciRah

h-index: 9
Works: 20
Citations: 1,409

Most-cited papers

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity
I. Bajrami, J. Frankum, Asha Konde, Rowan E. Miller +13 more
2013Cancer Research344 citations Open access
Semantic Scholar
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
C. Williamson, Rowan E. Miller, H. Pemberton, Samuel E. Jones +14 more
2016Nature Communications340 citations Open access
Semantic Scholar
PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
R. Chabanon, Gareth Muirhead, D. Krastev, J. Adam +19 more
2019Journal of Clinical Investigation293 citations Open access
Semantic Scholar
E-cadherin/ROS1 inhibitor synthetic lethality in breast cancer
I. Bajrami, Rebecca Marlow, M. van de Ven, R. Brough +27 more
2018Cancer Discovery106 citations Open access
Semantic Scholar
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
R. Chabanon, D. Morel, Thomas Eychenne, Léo Colmet-Daage +24 more
2021Cancer Research94 citations
Semantic Scholar
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
Sara Costa-Cabral, R. Brough, Asha Konde, M. Aarts +7 more
2016PLoS ONE77 citations Open access
Semantic Scholar
Modelling therapy resistance in BRCA1/2 mutant cancers
Amy Dréan, C. Williamson, R. Brough, I. Brandsma +13 more
2017Molecular Cancer Therapeutics76 citations Open access
Semantic Scholar
ATR is a therapeutic target in synovial sarcoma
Samuel E. Jones, Emmy D. G. Fleuren, J. Frankum, Asha Konde +15 more
2017Cancer Research54 citations Open access
Semantic Scholar
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma
J. Stewart, D. Krastev, R. Brough, D. Zatreanu +23 more
2025Oncogene12 citations Open access
Semantic Scholar
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
Sara Costa-Cabral, R. Brough, Asha Konde, M. Aarts +7 more
2016PLoS ONE6 citations Open access
Semantic Scholar
Abstract 6094: Longitudinal analysis of PARP inhibitor and platinum resistance in BRCA1/2m breast cancer using liquid biopsy
E. Harvey-Jones, Maya Raghunandan, Luisa Robbez-Masson, Alaguthurai Thanussuyah +17 more
2023Cancer Research4 citations
Semantic Scholar
Abstract 1058: Targeting chromatin remodeling-associated genetic vulnerabilities in cancer: PBRM1 defects are synthetic lethal with PARP and ATR inhibitors
R. Chabanon, D. Morel, Léo Colmet-Daage, Thomas Eychenne +16 more
2020Tumor Biology2 citations
Semantic Scholar
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
Sara Costa-Cabral, R. Brough, Asha Konde, M. Aarts +7 more
2018PLoS ONE2 citations Open access
Semantic Scholar
Abstract 2986: E-cadherin/ROS1 inhibitor synthetic lethality in breast cancer
I. Bajrami, Rebecca Marlow, M. van de Ven, R. Brough +25 more
2018Molecular and Cellular Biology / Genetics1 citations
Semantic Scholar
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
Sara Costa-Cabral, R. Brough, Asha Konde, M. Aarts +7 more
2017PLoS ONE1 citations Open access
Semantic Scholar
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer
V. Amodeo, D. Weekes, Nicolae Balan, Rebeca Uceda Castro +19 more
2026Nature Communications0 citations Open access
Semantic Scholar
PBRM1 deficiency in cancer is synthetic lethal with DNA repair inhibitors
R. Chabanon, D. Morel, Thomas Eychenne, Léo Colmet-Daage +24 more
20200 citations
Semantic Scholar
318 Novel therapeutic targets for ARID1A mutant ovarian clear cell carcinoma (OCCC)
Rowan E. Miller, I. Bajrami, R. Brough, Asha Konde +4 more
20140 citations
Semantic Scholar
Candidate drug therapies for molecularly defined subgroups of esophageal cancer identified from high-throughput drug screening.
I. Chong, D. Cunningham, R. Elliott, Asha Konde +6 more
20140 citations
Semantic Scholar
Abstract 2931: Cancer cells deficient in DNA mismatch repair (MMR) are selectively sensitive to inhibition of the DNA dependent protein kinase (DNA-PK)
M. Hewish, Yari Fontebasso, S. Martin, R. Elliott +7 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Lord×17
Invite
C. Lord — researcher profile on SciRah
A. Ashworth×13
Invite
A. Ashworth — researcher profile on SciRah
James Campbell×12
Invite
James Campbell — researcher profile on SciRah
R. Brough×11
Invite
R. Brough — researcher profile on SciRah

×10

Invite

S. Pettitt — researcher profile on SciRah

Invite

I. Bajrami — researcher profile on SciRah

Invite

J. Frankum — researcher profile on SciRah

Rumana Rafiq×6

Invite

Rumana Rafiq — researcher profile on SciRah

Aditi Gulati×6

Invite

Aditi Gulati — researcher profile on SciRah

H. Pemberton×5

Invite

H. Pemberton — researcher profile on SciRah

Invite

D. Krastev — researcher profile on SciRah

Malini Menon×5

Invite

Malini Menon — researcher profile on SciRah